Inflammatix – a visionary startup that uses host-response diagnostics to read the immune system – engaged Wonsupona to help them simplify their story to investors and audiences. After working with their team to deeply understand their product, we innovated the direction “Reimagining Diagnostics” which enabled them to talk about their brand in a myriad of new ways, unpacking the phrase as needed per topic and audience. This direction inspired a new brand story and messaging guidelines, complete with audience messages and key brand headlines.